Enterobiasis of the Ovary in a Patient With Cervical Carcinoma In Situ

by Kevin McCabe, Patricia A. K. Nahn, Aysegul A. Sahin, Michele Follen Mitchell
Published 1995-01-01

Non-glycanated Decorin Is a Drug Target on Human Adipose Stromal Cells

by Alexes C. Daquinag, Ali Dadbin, Brad Snyder, Xiaoping Wang, Aysegul A. Sahin, Naoto T. Ueno, Mikhail G. Kolonin
Published 2017-09-01

Outcomes of sentinel lymph node dissection alone vs. axillary lymph node dissection in early stage invasive lobular carcinoma: a retrospective study of the surveillance, epidemiolo...

by Jun Wang, Elizabeth A Mittendorf, Aysegul A Sahin, Min Yi, Abigail Caudle, Kelly K Hunt, Yun Wu
Published 2014-01-01

Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy.

by James Crespo, Hongxia Sun, Jimin Wu, Qing-Qing Ding, Guilin Tang, Melissa K Robinson, Hui Chen, Aysegul A Sahin, Bora Lim
Published 2020-01-01

Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells

by Debasish Tripathy, Khoa Nguyen, Stanley Ly, Vivek Anand, Fouad El-Dana, Yiming Cai, Shirong Cai, Helen Piwnica-Worms, Aysegul A Sahin, Michael Andreeff, Venkata Lokesh Battula
Published 2021-03-01

Atypical plant homeodomain of UBR7 functions as an H2BK120Ub ligase and breast tumor suppressor

by Santanu Adhikary, Deepavali Chakravarti, Christopher Terranova, Isha Sengupta, Mayinuer Maitituoheti, Anirban Dasgupta, Dushyant Kumar Srivastava, Junsheng Ma, Ayush T. Raman, Emily Tarco, Aysegul A. Sahin, Roland Bassett, Fei Yang, Coya Tapia, Siddhartha Roy, Kunal Rai, Chandrima Das
Published 2019-03-01

Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or <i>BRCA1</i> Alteration

by Xian Chen, Dong Yang, Jason P. W. Carey, Cansu Karakas, Constance Albarracin, Aysegul A. Sahin, Banu K. Arun, Merih Guray Durak, Mi Li, Mehrnoosh Kohansal, Tuyen N. Bui, Min Jin Ha, Kelly K. Hunt, Khandan Keyomarsi
Published 2021-04-01

Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy

by Shakuntala H. Mauzo, Michael T. Tetzlaff, Denái R. Milton, Alan E. Siroy, Priyadharsini Nagarajan, Carlos A. Torres-Cabala, Doina Ivan, Jonathan L. Curry, Courtney W. Hudgens, Jennifer A. Wargo, Aysegul A. Sahin, Curtis A. Pettaway, Victor G. Prieto, Phyu P. Aung
Published 2019-05-01

DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer.

by Steven T Lott, Nanyue Chen, Dawn S Chandler, Qifeng Yang, Luo Wang, Marivonne Rodriguez, Hongyan Xie, Seetharaman Balasenthil, Thomas A Buchholz, Aysegul A Sahin, Katrina Chaung, Baili Zhang, Shodimu-Emmanu Olufemi, Jinyun Chen, Henry Adams, Vimla Band, Adel K El-Naggar, Marsha L Frazier, Khandan Keyomarsi, Kelly K Hunt, Subrata Sen, Bruce Haffty, Stephen M Hewitt, Ralf Krahe, Ann McNeill Killary
Published 2009-05-01

Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity

by Chia-Wei Li, Seung-Oe Lim, Weiya Xia, Heng-Huan Lee, Li-Chuan Chan, Chu-Wei Kuo, Kay-Hooi Khoo, Shih-Shin Chang, Jong-Ho Cha, Taewan Kim, Jennifer L. Hsu, Yun Wu, Jung-Mao Hsu, Hirohito Yamaguchi, Qingqing Ding, Yan Wang, Jun Yao, Cheng-Chung Lee, Hsing-Ju Wu, Aysegul A. Sahin, James P. Allison, Dihua Yu, Gabriel N. Hortobagyi, Mien-Chie Hung
Published 2016-08-01